Kapoor Kapil G, Sim Jennifer
Wagner Macula and Retina Center, Virginia Beach, Virginia, USA.
Eastern Virginia Medical School, Norfolk, Virginia, USA.
Case Rep Ophthalmol. 2017 Jul 13;8(2):370-374. doi: 10.1159/000477757. eCollection 2017 May-Aug.
Central serous chorioretinopathy (CSCR) is potentially sight-threatening and has been associated with corticosteroid use. CSCR secondary to steroid use can sometimes be challenging to treat, especially if continuing steroid use is medically necessary. In this case report we demonstrate the efficacy of spironolactone as an effective agent in countering CSCR secondary to steroid use. This challenge-rechallenge case may be helpful to clinicians in delineating a treatment paradigm for these patients.
中心性浆液性脉络膜视网膜病变（CSCR）具有潜在的视力威胁，且与使用皮质类固醇有关。继发于类固醇使用的CSCR有时治疗起来具有挑战性，尤其是在继续使用类固醇在医学上是必要的情况下。在本病例报告中，我们证明了螺内酯作为一种有效药物在对抗继发于类固醇使用的CSCR方面的疗效。这个激发-再激发病例可能有助于临床医生为这些患者制定治疗方案。
